Clinical trial
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
NCT03496766
Study timeline
Study start (actual)2018-05-07Date precision: day
Registry last updated2025-03-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
TipifarnibDRUG
Sponsors & collaborators
Spanish Lung Cancer Grouplead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03496766 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.